Drug Topics
OCTOBER 2, 2024
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Lea Wolsoncroft of Remedies Pharmacy in Hoover, Alabama, discussed what is going on in her pharmacy practice.
Pharmacy Times
OCTOBER 2, 2024
Lowering prescription drug costs for patients, saving taxpayers money, helping small businesses level an anti-competitive playing field: all of this is at stake.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
OCTOBER 4, 2024
Experimental vaccines and therapeutics to combat the deadly Marburg virus will begin arriving this weekend in Rwanda, where they will be used in clinical trials expected to begin soon, a U.S. government official confirmed on Friday. There are currently no licensed vaccines or drugs to prevent or treat Marburg, a cousin of the Ebola family of viruses that transmits and causes illness in the same way as Ebola.
Fierce Pharma
OCTOBER 1, 2024
Johnson & Johnson is laying off 231 employees in New Jersey and Bayer is cutting 57 positions in the state, according to separate Worker Adjustment and Retraining Notification (WARN)
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
OCTOBER 3, 2024
Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.
Pharmacy Times
OCTOBER 2, 2024
Pharmacists and health care providers can counsel around vitamin D supplements and natural intake to increase a child’s vitamin D consumption.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Fierce Healthcare
OCTOBER 1, 2024
Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition. | Two key senators are urging the Federal Trade Commission to investigate "co-manufacturing" arrangements that they fear pharmacy benefit managers may be using to stymie competition.
Drug Topics
OCTOBER 4, 2024
Check out important updates from the FDA for the week of September 30.
Pharmacy Times
OCTOBER 1, 2024
The accelerated course was safe and effective and did not increase complications in patients with breast cancer post-mastectomy undergoing breast reconstruction.
STAT
OCTOBER 2, 2024
For nearly a year, my stance on Cassava Sciences and its Alzheimer’s disease drug candidate simufilam has been clear: Emerging evidence shows the drug is inert, and patients with Alzheimer’s were misled into participating in ongoing Phase 3 clinical trials, so therefore, the Food and Drug Administration must take immediate steps to protect these vulnerable people from further harm.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
OCTOBER 1, 2024
A new analysis points to troubling trends in the U.S. healthcare market as costs continue to rise but health outcomes are declining. | "The inputs of the U.S. healthcare system, as measured by cost, exceed the outputs, as measured by the actual value or benefits received by Americans," Sanjula Jain, Ph.D., Trilliant Health's chief research officer, said.
Drug Topics
OCTOBER 4, 2024
Social pressures, physiological changes, mental health challenges, and burnout all complicate diabetes management among adolescents.
Pharmacy Times
OCTOBER 4, 2024
The new screening test provides an easier, convenient option for patients seeking to screen themselves for colorectal cancer.
STAT
OCTOBER 1, 2024
A year ago last week, Jeanne Marrazzo stepped into a very big pair of shoes. Marrazzo became the first new director of the National Institute of Allergy and Infectious Diseases in decades, taking over a job held for 38 years by Anthony Fauci, whose long-term status as a science god in Washington gave way to Covid-19 fall guy in some quarters during and after the pandemic.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
OCTOBER 2, 2024
Gilead Sciences is wasting no time in promoting worldwide access to its twice-yearly pre-exposure prophylaxis (PrEP) HIV candidate lenacapavir. | The company will allow six generic manufacturers to make and sell its long-acting PrEP drug, lenacapivir, in 120 resource-limited countries.
Drug Topics
OCTOBER 1, 2024
Researchers compared the cardiovascular outcomes of patients hospitalized for heart failure that did or did not experience diabetic emergencies.
Pharmacy Times
OCTOBER 3, 2024
Fedratinib is an orally available, small molecule inhibitor of JAK-2 approved for treatment of myelofibrosis.
STAT
OCTOBER 1, 2024
Often, women with sickle cell disease are told not to have kids. They might come to an appointment, happily pregnant, only for the doctor to tell them they shouldn’t be. They might be preparing for a scheduled C-section when their OB-GYN says that this pregnancy has gone smoothly but the next one could kill them. The illness is associated with an increased risk of serious pregnancy complications, which warrants a discussion — but sometimes that discussion can blur the line between
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
OCTOBER 2, 2024
Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility fkansteiner Wed, 10/02/2024 - 07:31
Drug Topics
SEPTEMBER 30, 2024
Researchers addressed the association between older individuals who received an influenza vaccine and their risk of stroke following vaccination.
Pharmacy Times
SEPTEMBER 30, 2024
MDL-101 is a proposed novel precision medicine that targets the LAMA1 gene, causing LAMA2 congenital muscular dystrophy type 1a.
STAT
OCTOBER 3, 2024
Nearly 20 years after neuroscientist John Donoghue placed electrodes on Matthew Nagle’s motor cortex , allowing the man with no limb movement to control objects using his thoughts, the brain-computer interface field looks dramatically different — both the people doing the research and the technologies they are creating. Researchers like Leigh Hochberg and Eddie Chang and big-name startups such as Synchron and Paradromics have turned what was not too long ago an arcane academi
Fierce Healthcare
OCTOBER 1, 2024
Hospital programs providing at-home acute care are widely appreciated by patients and clinicians but still don’t have a bulletproof argument in respect to quality and costs as compared to a brick-a | A new 79-page government report on the soon-to-expire Acute Hospital Care at Home initiative outlines both clear-cut and muted wins for advocates.
Drug Topics
SEPTEMBER 28, 2024
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Pharmacy Times
SEPTEMBER 28, 2024
Experts discuss emerging targets in the immunotherapy landscape and how to improve patient outcomes through innovative approaches.
STAT
OCTOBER 2, 2024
Mapping the brain is a daunting task because it contains a huge number of cells and cell connections. It took almost 50 labs around the world to create a new neural map, or connectome, of an adult fruit fly — the largest map of its kind, and an effort that will allow researchers to better understand the brain’s inner workings. Access to the full connectome, as published Wednesday in a series of papers in Nature , could represent a new era for neuroscience, according to some re
IDStewardship
OCTOBER 3, 2024
Authored by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 30 September 2024 I recently had the honor to give a key note speech for my alma matter, Northeastern University in Boston, MA. It took me a while to put the thoughts together and I had some support from my friend Dr. Robert Kraljevich. It seems like other people might potentially benefit from reading this and learning from my 20 years of experience in the pharmacy biz… so I put it on this webpage!
Drug Topics
SEPTEMBER 28, 2024
Check out this recap of articles published on our sister sites during the past week.
Pharmacy Times
SEPTEMBER 28, 2024
Small molecule agents continue to be beneficial additions to multiple myeloma treatment, even with the development of T-cell redirected therapies.
STAT
SEPTEMBER 30, 2024
A large outbreak of Marburg virus in Rwanda is drawing international concern about the possibility of spread beyond the country’s borders. The number of cases detected so far, 27 , already makes the outbreak one of the biggest involving Marburg on record. Nine of those individuals have died. There are currently no licensed vaccines to combat the disease.
Fierce Pharma
OCTOBER 2, 2024
While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi has held a larger slice of the market than Johnson & Johnson’s riva | A real-world, head-to-head study of two androgen receptor pathway inhibiting (ARPI) prostate cancer drugs indicates that Johnson & Johnson’s Erleada provides an edge in overall survival versus Astellas and Pfizer’s Xtandi.
Drug Topics
SEPTEMBER 30, 2024
Sara T. Thomason discuses the impact of stigma on pharmacists who are dealing with substance use disorder, the importance of mental health care, and how schools support pharmacy students dealing with addiction.
Pharmacy Times
OCTOBER 4, 2024
The treatment aims to reduce prolonged QTc interval in patients with long QT syndrome.
Expert insights. Personalized for you.
201 
Let's personalize your content